ES2084995T3 - Composicion farmaceutica para el tratamiento de enfermedades malignas de los linfocitos b. - Google Patents

Composicion farmaceutica para el tratamiento de enfermedades malignas de los linfocitos b.

Info

Publication number
ES2084995T3
ES2084995T3 ES92901009T ES92901009T ES2084995T3 ES 2084995 T3 ES2084995 T3 ES 2084995T3 ES 92901009 T ES92901009 T ES 92901009T ES 92901009 T ES92901009 T ES 92901009T ES 2084995 T3 ES2084995 T3 ES 2084995T3
Authority
ES
Spain
Prior art keywords
lymphocytes
treatment
pharmaceutical composition
malignant diseases
cell malignancies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92901009T
Other languages
English (en)
Inventor
Jacques Banchereau
France Thierry De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schering Plough SAS
Schering Plough Corp
Original Assignee
Schering Plough SAS
Schering Plough Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough SAS, Schering Plough Corp filed Critical Schering Plough SAS
Application granted granted Critical
Publication of ES2084995T3 publication Critical patent/ES2084995T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPOSICIONES FARMACEUTICAS PARA EL TRATAMIENTO DE MALIGNIDADES DE CELULAS B EN UNA MAMA AFECTADA CON ESTAS MALIGNIDADES DE CELULAS B. DE FORMA MAS PRECISA, DE ACUERDO CON LA INVENCION, ESTAS COMPOSICIONES FARMACEUTICAS COMPRENDEN IL-4 COMO UN INGREDIENTE ACTIVO. LA PRESENTE INVENCION SE REFIERE TAMBIEN A UN METODO DE TRATAMIENTO DE MALIGNIDADES DE CELULAS B, O A LA INHIBICION DE LA PROLIFERACION O CRECIMIENTO DE CELULAS B MALIGNAS MEDIANTE LA ADMINISTRACION DE IL-4 A MAMAS QUE ESTAN AFECTADAS CON MALIGNIDADES DE CELULAS B.
ES92901009T 1990-12-13 1991-12-10 Composicion farmaceutica para el tratamiento de enfermedades malignas de los linfocitos b. Expired - Lifetime ES2084995T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90403585A EP0490006B1 (en) 1990-12-13 1990-12-13 Pharmaceutical compositions for the treatment of B-cell malignancies

Publications (1)

Publication Number Publication Date
ES2084995T3 true ES2084995T3 (es) 1996-05-16

Family

ID=8205785

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92901009T Expired - Lifetime ES2084995T3 (es) 1990-12-13 1991-12-10 Composicion farmaceutica para el tratamiento de enfermedades malignas de los linfocitos b.

Country Status (16)

Country Link
EP (2) EP0490006B1 (es)
JP (1) JPH06504767A (es)
AT (1) ATE135232T1 (es)
AU (1) AU9072191A (es)
CA (1) CA2098509A1 (es)
CZ (1) CZ113593A3 (es)
DE (1) DE69117974T2 (es)
DK (1) DK0561927T3 (es)
ES (1) ES2084995T3 (es)
FI (1) FI932650A0 (es)
GR (1) GR3019699T3 (es)
HU (1) HU210009B (es)
IE (1) IE64157B1 (es)
OA (1) OA09788A (es)
SK (1) SK59193A3 (es)
WO (1) WO1992010201A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106717A0 (en) * 1992-08-19 1993-12-08 Schering Corp Method for inhibiting hiv replication using il-4
US5679338A (en) * 1994-05-12 1997-10-21 Osteoarthritis Science, Inc. Use of IL-4 for inhibition of the breakdown of articular cartilage and other tissues
US5716612A (en) * 1994-09-07 1998-02-10 Schering Corporation Use of IL-4 for potentiation of chemotherapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0552243T3 (da) * 1990-09-06 1997-03-10 Schering Corp Anvendelse af interleukin-4 til behandling af faste tumorer

Also Published As

Publication number Publication date
EP0490006A1 (en) 1992-06-17
WO1992010201A1 (en) 1992-06-25
FI932650A (fi) 1993-06-10
JPH06504767A (ja) 1994-06-02
EP0490006B1 (en) 1994-06-22
CZ113593A3 (en) 1994-01-19
DE69117974D1 (de) 1996-04-18
AU9072191A (en) 1992-07-08
HU210009B (en) 1995-01-30
CA2098509A1 (en) 1992-06-14
OA09788A (en) 1994-04-15
HU9301719D0 (en) 1993-09-28
DK0561927T3 (da) 1996-07-29
HUT64478A (en) 1994-01-28
DE69117974T2 (de) 1996-07-25
IE64157B1 (en) 1995-07-12
SK59193A3 (en) 1994-01-12
FI932650A0 (fi) 1993-06-10
EP0561927A1 (en) 1993-09-29
GR3019699T3 (en) 1996-07-31
IE914328A1 (en) 1992-06-17
EP0561927B1 (en) 1996-03-13
ATE135232T1 (de) 1996-03-15

Similar Documents

Publication Publication Date Title
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
ES8705393A1 (es) Un procedimiento para preparar un derivado de pirazol (como divisional de la solicitud de patente de invencion n 543.046, presentada el 10.5.85)
GR3022321T3 (en) Use of il-4 to treat solid tumors
PT86520A (en) Process for preparing 2,4,5-trisubstituted phenol derivatives useful as anti-inflammatory agents
ES8400742A1 (es) Procedimiento de preparacion de las dibenzooxepinas sustituidas y de sus sales de adicion con un acido mineral u organi-co.
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
ES2084995T3 (es) Composicion farmaceutica para el tratamiento de enfermedades malignas de los linfocitos b.
ES2128314T3 (es) Nuevos inductores potentes de diferenciacion terminal y metodo de utilizacion de los mismos.
DE3362328D1 (en) (1-arylcyclobutyl) (heterocyclyl) methylamine compounds, their preparation and their use as therapeutic agents
EA200001029A1 (ru) Производные гигромицина
DE2966809D1 (en) 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them
ES527353A0 (es) Procedimiento de preparacion de nuevos derivados de la nitrosourea
FI810380L (fi) Fenylpiperazinderivat av 1,3,4-oxadiazolylfenoler deras framstaellning och dessa innehaollande terapeutiska aemnen
JPS5695116A (en) Xanthine oxidase inhibitor and therapeutic treatment thereby
GR78622B (es)
DE3368199D1 (en) Mixture comprising a central analgesic and vitamin b12, or one of its analogs, as active principles
ES2071793T3 (es) Nuevos derivados de la pirrolidona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
AU583247B2 (en) Heteroaryloxypropanolamines
EA200001028A1 (ru) Производные 2"-деоксигигромицина
EP0276805A3 (en) Substituted 3-phenyl-7h-thiazoloû3,2-b¨û1,2,4¨triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds
ES367589A1 (es) Un procedimiento para la preparacion de un 2,3,5,9 b-tetra-hidro-5h-imidazo (2,i-a) isoindol-5-ol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 561927

Country of ref document: ES